Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Card IncomeConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest ExpensesInterest Income - Debt SecuritiesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest Income - TotalInterest income - LoansInvestment Banking IncomeNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueService ChargesShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Central Plains Bancshares (CPBI) Research & Development (2022 - 2025)

Central Plains Bancshares has reported Research & Development over the past 3 years, most recently at $526000.0 for Q1 2025.

  • Quarterly Research & Development rose 14.35% to $526000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2025, up 8.76% year-over-year, with the annual reading at $2.0 million for FY2025, 8.76% up from the prior year.
  • Research & Development was $526000.0 for Q1 2025 at Central Plains Bancshares, up from $476000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $526000.0 in Q1 2025 and troughed at $443000.0 in Q2 2023.
  • The 3-year median for Research & Development is $463000.0 (2023), against an average of $476500.0.
  • Year-over-year, Research & Development grew 3.7% in 2024 and then grew 14.35% in 2025.
  • A 3-year view of Research & Development shows it stood at $459000.0 in 2023, then grew by 3.7% to $476000.0 in 2024, then rose by 10.5% to $526000.0 in 2025.
  • Per Business Quant, the three most recent readings for CPBI's Research & Development are $526000.0 (Q1 2025), $476000.0 (Q4 2024), and $522000.0 (Q3 2024).